Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
03/2003
03/04/2003US6528538 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharamaceutical compositions and preparation process
03/04/2003US6527816 Isosorbide derivatives that can be used in detergent compositions for gasoline-type fuels
02/2003
02/27/2003WO2003015765A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
02/27/2003WO2002056835A3 Anticancer treatment using triptolide prodrugs
02/27/2003US20030040623 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses
02/27/2003CA2457644A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
02/26/2003EP1284741A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
02/26/2003EP0941221B1 Substituted dihydrobenzofurans as pde inhibitors
02/25/2003US6525088 Agent for measurement of singlet oxygen
02/25/2003US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
02/25/2003US6524382 Pigmented vitreous material
02/25/2003CA2039401C Preparation of optically active norbornyl amine derivatives
02/20/2003WO2003014063A2 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
02/20/2003WO2002079183A8 Halogenated rhodamine derivatives and applications thereof
02/20/2003WO2002022621B1 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS
02/20/2003US20030036661 For therapy of cancer
02/20/2003US20030036603 E.g., spiro(7-oxa-5-norbornene-2,3'- succinic anhydride, -tetrahydrofuran-2'-one, and -(2',2'-dimethyl)tetrahydrofuran))
02/20/2003US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
02/20/2003CA2456255A1 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
02/19/2003EP1283840A2 Process for the manufacture of anhydro sugar alcohols
02/19/2003EP0931083B1 Process for producing ecteinascidin compounds
02/19/2003EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
02/19/2003CN1397558A Prepn. process of spiroacetal derivative
02/19/2003CN1101819C 4-beta-carbonsubstituted-4-deoxy-4'-demethylepi podophyllotoxin derivative with antineoplastic activity and its synthesis method and intermediate
02/18/2003US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
02/13/2003WO2003011867A1 Use of soraphen derivatives
02/13/2003WO2002083657A3 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
02/13/2003US20030032816 Gas-phase oxidation of a tetraalkylbenzene and/or a trialkylbenzaldehyde in a fixed-bed type reactor having a catalyst bed that has </= 2% moisture
02/13/2003US20030032813 Parathyroid hormone receptor-mediated adenylate cyclase formation; treating osteoporosis
02/13/2003US20030031736 Treating an aqueous suspension of Ginkgo biloba plant material or extract with an oxidizer, extracting the terpene trilactones and separating the organic layer containing the terpene trilactones from the aqueous layer; purification
02/12/2003EP1282618A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
02/12/2003EP1115400A4 Benzothiazole dioxetanes
02/12/2003EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use
02/12/2003CN1396166A Process for preparing general valerianin
02/11/2003US6518426 Pyrimidine derivatives and methods of making and using these derivatives
02/10/2003WO2002012229A1 Heterocyclylalkyl azole derivatives and use thereof as pesticidal agents
02/10/2003CA2418945A1 Heterocyclylalkylazole derivatives and their use as pesticides
02/06/2003WO2003010138A2 Piperidine derivatives as antibacterial agents
02/06/2003WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors
02/06/2003WO2002030937A3 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay
02/06/2003US20030028037 Process for producing spiro acetal derivative
02/06/2003US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV)
02/06/2003US20030027855 Preparation of a derivative or analog of baccatin III or 10-desacetyl baccatin III having a C9 hydroxy substituent by selective reduction of the C9 keto compound
02/06/2003US20030027806 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
02/06/2003US20030027238 Optical molecular sensors for cytochrome P450 activity
02/06/2003US20030026922 Chiral compounds
02/05/2003EP1281712A1 Fluorescent pH indicators for intracellular assays
02/05/2003EP1280559A2 Acylated cyclodextrin guest inclusion complexes
02/05/2003EP0745087B1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents
02/05/2003CN1395579A Method for synthesis of alpha-D-GA (1-3) GAL-containing oligosaccharides
02/05/2003CN1394862A Chiral compound
02/05/2003CN1100782C 5-aver mectin B1a ester and 5-ivermectin B1a grease and synthesis method and use
02/05/2003CN1100781C FT-0554 substance, producing method and use, and microbial for separating them
02/05/2003CN1100762C Substituted pyrazolyl-pyrazole derivatives and their use as herbicides
02/04/2003US6515167 Said process comprising reacting a carboxylic acid or salt thereof having formula (I) with dimethyl carbonate having formula (II) in the presence of a catalyst selected from the group consisting of 1,8 diazabicyclo(5.4.0)undec-7-ene;
02/04/2003US6515152 Process for production of an oxetane
02/04/2003US6515137 Enantioselectivity of alpha,beta-unsaturated aldehydes
02/04/2003US6514987 Useful for inactivating pathogens in a material, such as a blood product, and then degrades to breakdown products
02/04/2003US6514687 Screening a candidate compound for activity as a Cytochrome P450 enzyme substrate by contacting the compound, enzyme, and a reagent chromogen comprising the ether of a phenolic dye such as a coumarin, resofurin or fluorescein dye
01/2003
01/30/2003WO2003007878A2 Antifungal agents of sordarin derivatives
01/30/2003WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use
01/30/2003US20030022930 Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine as inhibitors of glutamate transport
01/30/2003US20030022903 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/30/2003US20030022902 Based upon 2-(N-(7-benzyl-9-methyl-1,5-dioxonan-2,6-dione-3-yl)amido)-3-hydroxy-4 -methoxypyridine; use as agricultural fungicide
01/30/2003US20030022885 Pyrazole compounds useful as protein kinase inhibitors
01/29/2003EP1278753A2 Peroxide-based antimalarial compounds
01/29/2003EP1278752A1 Improved synthesis of anhydroglycitol esters of improved colour
01/29/2003EP1278742A1 Chromenylmethylpyrimidinediamines as antibacterial agents
01/29/2003EP0983255B1 Substituted 2-benzoyl-cyclohexane-1,3-diones
01/29/2003EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
01/29/2003CN1393447A Process for purifying sym-phenyltetraformic acid dianhydride
01/28/2003US6512030 Plastic additives which are useful as nucleating agents and which are especially useful for improving the optical properties of polymeric materials such as polyolefins; also as gelling agents for antiperspirant gels
01/28/2003US6512003 Synthetic spiroketal pyranes as potent anti-cancer agents and use
01/28/2003US6511999 Treating rheumatoid arthritis and psoriasis, reproductive disorders, bronchoconstrictive disorders (asthma), osteoporosis, peptic ulcers, heart disease, and thrombosis
01/28/2003US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia
01/28/2003US6511976 Having antipsychotic, cardiovascular and gastrokinetic activity
01/28/2003US6511942 Animal husbandry, veterinary medicine
01/23/2003WO2003006467A1 Novel anticonvulsant derivative salts
01/23/2003WO2003006060A1 Sh3 domain binding inhibitors
01/23/2003WO2003006040A1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
01/23/2003WO2002066475A3 Tricyclic androgen receptor modulator compounds
01/23/2003WO2002060436A3 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states
01/23/2003WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors
01/23/2003US20030018065 Bridged tricyclid analogs of 2-(carboxycyclopropyl)glycine
01/23/2003US20030018052 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/23/2003US20030018046 Chemokine receptor binding heterocyclic compounds
01/23/2003US20030018012 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/23/2003CA2453467A1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
01/23/2003CA2452612A1 Novel anticonvulsant derivative salts
01/22/2003EP1277751A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277749A1 2- and 2,5-substituted phenylketo enols
01/22/2003EP1277735A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277734A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277733A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1276748A1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
01/22/2003EP1276740A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
01/22/2003EP1276734A1 Halogenated rhodamine derivatives and applications thereof
01/22/2003EP1025104B1 7-methylidene-5-oxo-furo fused naphthopyrans
01/22/2003CN1392252A Cultivating method for increasing sweet wormwood organ biomass and artemisine content
01/21/2003US6509371 Compositions containing Bergamottin for increasing the oral bioavailability of pharmaceutical agents